BioCentury
ARTICLE | Clinical News

Gliadel Wafer regulatory update

October 4, 2004 7:00 AM UTC

FDA granted Orphan Drug designation to Gliadel wafer carmustine implant to treat patients with malignant glioma undergoing primary surgical resection. ...